BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12440164)

  • 1. WVMI provides follow-up on beta blocker use.
    Schade CP
    W V Med J; 2002; 98(5):183. PubMed ID: 12440164
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta blocker use in acute myocardial infarction in West Virginia.
    Schade CP; Brehm JG; Stephens MK; Rezek G
    W V Med J; 2002; 98(2):56-60. PubMed ID: 12048739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study outlines key factors in successful beta-blocker use.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):1-2, 5. PubMed ID: 12182170
    [No Abstract]   [Full Text] [Related]  

  • 4. Are beta-blockers really underutilized in postinfarction patients?
    O'Rourke RA
    J Am Coll Cardiol; 1995 Nov; 26(6):1437-9. PubMed ID: 7594067
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriers.
    Kavookjian J; Mamidi S
    Clin Ther; 2008; 30 Pt 2():2241-9. PubMed ID: 19281918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elderly AMI patients don't always get beta-blockers.
    Hosp Case Manag; 2006 Dec; 14(12):191-2. PubMed ID: 17137236
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
    Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why aren't we using beta blockers after acute MI?
    Weichel AS
    Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
    [No Abstract]   [Full Text] [Related]  

  • 9. A slow trickledown. Data on efficacy of beta blockers belatedly spur use.
    Moore JD
    Mod Healthc; 1998 Sep; 28(37):70. PubMed ID: 10183097
    [No Abstract]   [Full Text] [Related]  

  • 10. Initiative raises use of interventions that prevent second heart attacks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Jul; 11(14):8-10. PubMed ID: 11771563
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers underutilized.
    Tracy GE
    S D J Med; 2001 May; 54(5):185. PubMed ID: 11392204
    [No Abstract]   [Full Text] [Related]  

  • 14. Physician prescribing and the hippocratic oath.
    Mullins CD
    Clin Ther; 2005 May; 27(5):628-9. PubMed ID: 15978312
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospitals boost performance with beta blocker data.
    Data Strateg Benchmarks; 2001 Oct; 5(10):149-51, 145. PubMed ID: 11682807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study.
    Silvet H; Spencer F; Yarzebski J; Lessard D; Gore JM; Goldberg RJ
    Arch Intern Med; 2003 Oct; 163(18):2175-83. PubMed ID: 14557215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do capitated physicians have more incentive to prescribe beta-blocker therapy?
    Capitation Rates Data; 2004 Jun; 9(6):68-70. PubMed ID: 15279362
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM; Bell D; Islam SS; Scott VG
    Ann Pharmacother; 2005 Sep; 39(9):1416-22. PubMed ID: 15972326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.